We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$107M
1-Year Est. Return
82.62%
This Fund
S&P 500
This Quarter
Est. Return
+17.18%
1 Year Est. Return
+82.62%
3 Year Est. Return
+219.47%
5 Year Est. Return
+202.9%
10 Year Est. Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
98.65%
Top 10 Holdings %
Top 10 Hldgs %
40.45%
Holding
93
New
93
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
NeoGenomics
NEO
|
+$7.42M |
| 2 |
Vericel Corp
VCEL
|
+$4.58M |
| 3 |
Veracyte
VCYT
|
+$4.15M |
| 4 |
Idexx Laboratories
IDXX
|
+$4.14M |
| 5 |
CareDx
CDNA
|
+$4.04M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 65.3% |
| 2 | Technology | 12.81% |
| 3 | Communication Services | 6.99% |
| 4 | Industrials | 4.39% |
| 5 | Consumer Staples | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.88B
| $7.36M | 6.76% |
+199,525
| New | +$7.42M |
|
|
2
Vericel Corp
VCEL
$2.39B
| $5.13M | 4.71% |
+276,897
| New | +$4.58M |
|
3
Natera
NTRA
$39.6B
| $5.11M | 4.69% |
+70,700
| New | +$4.02M |
|
|
4
CareDx
CDNA
$1.53B
| $4.54M | 4.17% |
+119,592
| New | +$4.04M |
|
|
5
Idexx Laboratories
IDXX
$44.3B
| $4.41M | 4.05% |
+11,205
| New | +$4.14M |
|
|
6
Veracyte
VCYT
$4.71B
| $4.24M | 3.9% |
+130,580
| New | +$4.15M |
|
7
OptimizeRx
OPRX
$126M
| $3.52M | 3.23% |
+168,760
| New | +$2.9M |
|
8
Microsoft
MSFT
$2.93T
| $3.36M | 3.09% |
+15,993
| New | +$3.36M |
|
9
Axogen
AXGN
$2.04B
| $3.33M | 3.06% |
+286,190
| New | +$3.32M |
|
10
Abbott
ABT
$154B
| $3.05M | 2.8% |
+28,030
| New | +$2.84M |
|
11
Standard BioTools
LAB
$337M
| $2.47M | 2.27% |
+332,425
| New | +$2.29M |
|
|
FPAY
12
DELISTED
FlexShopper
FPAY
| $2.15M | 1.98% |
+1,217,130
| New | +$2.08M |
|
|
CSII
13
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.14M | 1.97% |
+54,450
| New | +$1.76M |
|
14
Eli Lilly
LLY
$1.03T
| $2.07M | 1.9% |
+13,958
| New | +$2.16M |
|
15
Rockwell Medical
RMTI
$22.3M
| $1.97M | 1.81% |
+16,766
| New | +$2.9M |
|
16
Magnite
MGNI
$2.93B
| $1.92M | 1.77% |
+277,000
| New | +$1.85M |
|
17
LeMaitre Vascular
LMAT
$2.26B
| $1.84M | 1.69% |
+56,700
| New | +$1.7M |
|
18
BioLife Solutions
BLFS
$1.44B
| $1.84M | 1.69% |
+63,650
| New | +$1.37M |
|
19
Castle Biosciences
CSTL
$726M
| $1.8M | 1.65% |
+34,900
| New | +$1.55M |
|
20
Pfizer
PFE
$141B
| $1.77M | 1.63% |
+50,985
| New | +$1.79M |
|
21
AtriCure
ATRC
$1.76B
| $1.77M | 1.63% |
+44,350
| New | +$1.88M |
|
|
ASPU
22
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.71M | 1.57% |
+152,750
| New | +$1.63M |
|
23
Inuvo
INUV
$21.2M
| $1.7M | 1.56% |
+464,021
| New | +$2.3M |
|
|
QUMU
24
DELISTED
Qumu Corp.
QUMU
| $1.66M | 1.53% |
+361,000
| New | +$1.82M |
|
|
AKTS
25
DELISTED
Akoustis Technologies Inc
AKTS
| $1.59M | 1.46% |
+195,300
| New | +$1.58M |
|
Similar funds
EWL
ECM
HCA
LLI
RSEWM
CWM
SNPAM
ACL